EFFECTS OF METHANOL LEAF EXTRACTS OF GREEN AMARANTH (AMARANTHUS HYBRIDUS) AND FLUTED PUMPKIN (TELFAIRIA OCCIDENTALIS) ON ASPARTAME –INDUCED OXIDATIVE STRESS IN WISTAR ALBINO RATS

  • 0 Review(s)

Product Category: Projects

Product Code: 00007259

No of Pages: 93

No of Chapters: 1-5

File Format: Microsoft Word

Price :

$20

ABSTRACT


The effects of methanol leaf extracts of Telfairia occidentalis. and Amaranthus hybridus on aspartame-induced oxidative stress in wistar Albino rats was investigated. Rats were randomly selected and divided into 5 groups (5 rats per group) and acclimatized for two weeks. Group 1 was the normal group. Group II (negative control) was given aspartame (40 mg/kg b.w) for 40 days. Groups III and IV were also given aspartame but treated with 200 mg/kg b.w methanol leaf extracts of Amaranthus hybridus  and Telfairia  occidentalis respectively. Group V was also given aspartame but subjected to co-administration of 100 mg/kg b.w each of both methanol leaf extracts of Amaranthus hybridus and Telfairia occidentalis in the ratio of 1:1 for 40 days. All the rats were fed with commercial rat chow and water ad libitum throughout the experimental period. They were then sacrificed after an overnight fast and blood collected for determination of various parameters. The results revealed a significant increase (p<0.05) in malondialdehyde (MDA) concentration in Group II (negative control) compared to the normal and treated groups III and IV but Group V recorded a significant decrease (p<0.05) in the MDA concentration compared to the other treated groups and the normal. The activities of the antioxidant enzymes superoxide dismutase and catalase were significantly decreased (p<0.05) in Group II (negative control) compared to the normal and the treated groups though catalase activity was significantly lower (p< 0.05) in the normal compared to the other treated groups. Total cholesterol concentration was significantly increased (p<0.05) in Group IV compared to other test groups and the normal while there was a significant decrease (p<0.05) in Group V compared to the normal. LDL-cholesterol concentration in Group II (negative control) recorded a significantly high increase (p<0.05) compared to all the other groups and the normal. There were no significant changes in triacylglycerols (TAGs), HDL-cholesterol and VLDL (p>0.05) in all the groups compared to the normal. Liver enzymes activity showed no significant change in AST (p>0.05) while ALT was significantly decreased (p<0.05) in all the groups compared to the normal. ALP was significantly decreased (p<0.05) in all the treated groups and the negative control compared to the normal. Total bilirubin concentration was significantly increased (p<0.05) in group V compared to the normal and the other test groups. Direct bilirubin was significantly decreased (p<0.05) in Group II and in Group III compared to the normal and the other treated groups. Total protein and globulins were significantly increased (p<0.05) in all the treated groups compared to the normal and the negative control. Albumin concentration showed no significant change (p>0.05) in all the groups compared to the normal. Serum creatinine and urea concentrations recorded no significant change (p>0.05) in all the treated groups and in the negative control group compared to the normal. These results suggest that aspartame has oxidative properties as evidenced by the significantly increased MDA concentration and decreased activities of the antioxidant enzymes in Group II (negative control) compared to the normal and the treated groups while Amaranthus hybridus and Telfairia occidentalis may have antioxidant capacities that can ameliorate oxidative stress.






TABLE OF CONTENTS

Title Page                                                                                                                                i

Declaration                                                                                                                              ii

Certification                                                                                                                            iii

Dedication                                                                                                                              iv

Acknowledgements                                                                                                                v

Table of Contents                                                                                                                   vi

List of Tables                                                                                                                          x

List of Plates                                                                                                                           xi

Abstract                                                                                                                                  xii

 

CHAPTER 1: INTRODUCTION                                                                                     

1.1       Background of the Study                                                                                           1

1.2       Statement of the Problem                                                                                           4

1.3       Aim of the Study                                                                                                        4

1.4       Objectives of the Study                                                                                              4

1.5       Scope                                                                                                                          5

1.6       Significance of the Study                                                                                           5

1.7       Justification of the Study                                                                                           5

 

CHAPTER 2: LITERATURE REVIEW                                                                         

2.1       Description of Telfairia occidentalis                                                                           6

2.1.1    Scientific classification of Telfairia occidentalis                                                        7

2.1.2    Structure, cultivation and storage                                                                               8

2.1.3    Nutritional potentials of Telfairia occidentalis                                                           9

2.1.4    Medicinal properties/health benefits of Telfairia occidentalis                                    11

2.2       Description of Amaranthus hybridus                                                                          14

2.2.1    Scientific classification of Amaranthus hybridus                                                       15

2.2.2    Distribution                                                                                                                 16

2.2.3    Nutritional potentials of Amaranthus hybridus                                                          17

2.2.4    Medicinal properties/health benefits of Amaranthus hybridus                                   17

2.3       Aspartame                                                                                                                   21

2.3.1    Chemistry and mechanism of action                                                                           21

2.3.2    Uses of aspartame                                                                                                       22

2.3.3    Safety and health effects                                                                                            23

2.4       Oxidative Stress                                                                                                          24

2.4.1    Causes of oxidative stress                                                                                           24

2.4.2    Oxidants and their sources                                                                                         26

2.5       Lipid Profile                                                                                                                28

2.6       Liver Function                                                                                                            29

2.6.1    Liver function and enzyme markers                                                                           29

2.6.2    Plasma and serum proteins                                                                                          32

2.6.3    Bilirubin                                                                                                                      32

2.7       Kidney Function and Kidney Function Tests                                                            32

 

 

CHAPTER 3: MATERIALS AND METHODS                                                  

3.1       Materials                                                                                                                     34

3.1.1    Plant materials sampling                                                                                             34

3.1.2    List of chemicals used                                                                                                34

3.1.3    List of apparatus and instruments                                                                               35

3.2       Methods                                                                                                                      36

3.2.1    Extraction of plant materials                                                                                       36

3.2.2    Experimental design and animal grouping                                                                  36

3.2.3    Collection of blood and preparation of serum samples                                              37

3.3       Biochemical Assay                                                                                                      37

3.3.1    Assay for lipid peroxidation (malondialdehyde)                                                        37

3.3.2    Antioxidant assays                                                                                                      38

3.3.2.1 Determination of catalase activity                                                                              38

3.3.2.2   Determination of superoxide dismutase (SOD) activity                                          39

3.3.3    Determination of serum lipid profile                                                                          40

3.3.3.1 Determination of total cholesterol (TC)                                                                      40

3.3.3.2 Determination of triacylglycerols (TAGs)                                                                 41

3.3.3.3  Determination of HDL – cholesterol                                                                         42

3.3.3.4  Estimation of LDL– cholesterol                                                                                42

3.3.3.5 Estimation of VLDL                                                                                                 42

3.3.4    Analyses of liver function                                                                                           43

3.3.4.1   Determination of serum aspartate amino transferase (AST) activity                        43

3.3.4.2 Determination of serum alanine amino transferase (ALT) activity                             44

3.3.4.3 Determination of serum alkaline phosphatase (ALP) activity                                    44

3.3.4.4 Determination of serum bilirubin fractions                                                                 45

3.3.4.4.1 Determination of total bilirubin                                                                               45

3.3.4.4.2 Determination of direct bilirubin                                                                             46

3.3.5    Analyses of proteins                                                                                                   46

3.3.5.1 Determination of serum total proteins (TP)                                                                46

3.3.5.2 Determination of serum albumin                                                                                47

3.3.5.3 Determination of globulins                                                                                         48

3.3.6    Determination of kidney function parameters                                                            48

3.3.6.1 Determination of serum creatinine                                                                              48

3.3.6.2 Determination of serum urea                                                                                      49       

3.4         Statistical Analysis                                                                                                    50

 

CHAPTER 4: RESULTS AND DISCUSSION                                                   

4.1       Results                                                                                                                        51

4.2       Discussion                                                                                                                   57

 

CHAPTER 5: CONCLUSION AND RECOMMENDATIONS                        

5.1       Conclusion                                                                                                                  65

5.2       Recommendations                                                                                                      65

            References                                                                                                                  66

            Appendices                                                                                                                 76

 

 

 

 

 

LIST OF TABLES

                                                                                                                                                Page

4.1:      Effects of Amaranthus hybridus  and Telfairia occidentalis methanol

            leaf extracts on malonaldehyde concentration (lipid peroxidation marker)

            in aspartame-treated rats                                                                                             51

 

4.2:      Effects of Amaranthus hybridus  and Telfairia occidentalis methanol leaf  

            extracts on some antioxidant enzymes in aspartame –treated rats.-                           52

 

4.3       Effects of Amaranthus hybridus  and Telfairia occidentalis methanol

leaf extracts on the lipid profile of aspartame –treated rats                                       53       

4.4       Effect of of Amaranthus hybridus  and Telfairia occidentalis methanol

            leaf extracts on  liver function of aspartame – treated rats.                                        54

4.4 (a)  Activities of liver enzymes

4.4 (b) Effects of Amaranthus hybridus  and Telfairia occidentalis methanol

            leaf extracts on liver function of aspartame – treated rats                                          55

4.4(c)   Effects of Amaranthus hybridus  and Telfairia  occidentalis methanol

            leaf extracts on other parameters of liver function of aspartame-treated rats            56

 

4.5:      Effects of Amaranthus hybridus  and Telfairia  occidentalis methanol leaf               extracts on some kidney functions parameters of aspartame –treated rats                    57

           

                                                                                   

 

 

 

 

LIST OF PLATES

2.1:      Plate showing young shoots, leaves and fruit of Telfairia occidentalis          8

2.2:      Plate showing the leaves, stems and seeds of Amaranthus hybridus             16

 

 

 

 

 



 

 

CHAPTER 1

INTRODUCTION

 

1.1              BACKGROUND OF THE STUDY

        Green leafy vegetables are an essential component of the foods consumed by animals and humans. Biblically the foods given to man by God and animals after creation were basically foods of plant origin. It is believed that God gave man the permission to eat foods of animal origin because plants had not yet begun to grow and yield fruits immediately after the flood, and so only foods derived from the animals in Noah’s ark were available for immediate consumption (Malkmus et al., 2006).

 

        A diet consisting mainly of vegetables, fruits, whole grain cereals rich in unrefined carbohydrate and dietary fibre is best for maintenance of good health because most plants generally have good medicinal properties. This is principally because plants contain a wide variety of vitamins and phytochemicals which promote good health. Also, the dietary fibre present in plants, in whole grain cereals and unrefined carbohydrate further contribute to good health and protects against disease. Together with the phytochemicals such as flavonoids and the antioxidant vitamins like vitamin C and E, plant-based food products can act as scavengers of oxygen- derived free radicals (Rolfe et al., 2006) which are generated inherently from normal metabolic reactions in the body, and also in part by environmental factors such as pesticide residues in foods and ionizing radiation which one cannot help being exposed to due to increasing industrialization and the rural –urban drift. The need to include more vegetables in our diet so as to maintain good health is gaining increasing importance in recent times. The enormous benefits of eating more fruits and vegetables on a daily basis have been unraveled by many researchers (Rolfe et al.,2006; Kayode and Kayode, 2011; Usunobun and Egharebva, 2014). Plants not only provide the nutrients needed for growth and development, they also provide phytochemicals against many diseases. The art of using plants for medicinal purposes is as old as man himself and the search for medicinal plants is unending because of the many advantages they confer.

        The increasing use of food additives, chemical preservatives and food flavor enhancers is a major health concern. Aspartame is an artificial sweetener used in food products as a sugar alternative. Its sweetness is about 200 times more than that of sugar thus it is used in low-calorie soft drinks and foods. Aspartame was discovered serendipitously in 1965 by researchers trying to come up with a new anti-ulcer drug. It was approved by the Food Drug Administration (FDA) In 1981 to be used in dry applications and then certified for use in carbonated beverages in 1983 and as a general sweetener in 1986 (Butchko et al., 2002). When ingested, aspartame is hydrolyzed by digestive esterases and peptidases in the intestinal lumen to methanol and the amino acids phenylalanine and aspartate and this increases the concentration of these metabolites in the blood (Stegink et al., 1987). A panel of experts in 2013 concluded that at current level of exposure, aspartame is safe for human consumption (El-bahr, 2013). Up till 2017, evidence does not support a long term benefit for weight loss or for diabetics (Azad et al., 2017). People with the inborn error, phenylketonuria (PKU), must be careful of products which contain aspartame because of phenylalanine which is one of its breakdown products.

        Even though aspartame produces 4 kcal of energy per gram (17 KJ/g) when metabolized, its caloric contribution is negligible because only very minute quantity is needed for it to produce sweetness (Magnuson et al., 2007). The sweetness of aspartame outlasts that of sucrose and so it is usually blended with other artificial sweeteners such as acesulfame potassium to produce an overall taste like that of sugar (O’Donnel, 2006).

Since being approved as an artificial sweetener in 1981, aspartame has been the subject of much controversy regarding its effects on health. There have been concerns that aspartame might be carcinogenic (Olney, 1996). Reports reveal that aspartame causes headaches, seizures and mood changes (Magnuson et al., 2007). However, these claims have been disputed by other researchers. The toxicity of aspartame has been linked to its pro-oxidative effects in animal studies.

        Most diseases such as cancer, asthma, cardiovascular diseases, diabetes mellitus, arthritis etc, and aging are associated with oxidative stress (Rolfe et al., 2006, Murray, 2006; Chitanya et al., 2010). Oxidative stress results when there is excessive production of oxygen- derived free radicals in cells. This could overpower the normal antioxidant capacity of the cells to detoxify free radicals. When the concentration of oxygen-derived free radicals is more than the antioxidants species such as tocopherols, ascorbic acid and glutathione or enzymes involved in oxygen radical scavenging (catalase, peroxidases, and superoxide dismutase (SOD), oxidative damage occurs to proteins, lipids and DNA, leading to cytotoxicity, mutation and carcinogenesis (Murray, 2006; El-bahr, 2013).

        Telfairia occidentalis is a creeping vegetable plant widely cultivated in West Africa for its succulent leaves and edible seeds.  Common names for the plant include fluted gourd; fluted pumpkin; “Ugu” and “Ikong Ubong” in the Igbo and Efik/Ibibio languages respectively. It is a member of the Curcubitaceae family, and is native to Southern Nigeria. It is highly coveted because of its high nutritive value and healing properties. Interest is constantly increasing in the use of this vegetable to combat hepatotoxicity (Kayode et al., 2011), because the leaves and young shoots are rich in phytochemicals and antioxidants (Adaramoye et al.,2007; Kayode et al., 2009;  Kayode et al., 2010).

Several authors have reported the ability of Telfairia occidentalis in protecting against liver damage (Oboh et al., 2005).

Amaranthus hybridus, commonly called green amaranth is a herbal plant usually grown for consumption. It is named “Terere” in most communities in Kenya and is cultivated in various areas of the world such as South America, Africa, India, China and the United States (Kavita and Ghandi , 2002). This vegetable is a known important source of iron. The leaves of this plant is said to have many medicinal properties; tea produced from the leaves of Amaranthus hybridus is astringent and is used for treating intestinal bleeding, diarrhea, and excessive menstruation (Foster and Duke, 1990).

        Oxidative stress is the underlying cause of many debilitating diseases and this has been well documented in the literature (Murray, 2006; Friedovich, 2007). It is also a fact that plant-based diets and leafy vegetables generally have beneficial effects on health. It is also worthy of note that no matter how harmless synthetic food additives may be, the body still recognizes them as foreign compounds and this may result in reactions which may be injurious to health (Malkmus et al., 2006). This study therefore sought to explore the potentials of these two plants – Telfairia occidentalis and Amaranthus hybridus against the effect of aspartame, by investigating numerous biochemical parameters which may give an insight into the health effect of aspartame vis-à-vis the opposing and/or interactive effects of these plants.

     1.2            STATEMENT OF THE PROBLEM

        There is an increasing use of aspartame in mineral drinks, candies, pharmaceuticals etc. in place of sucrose. It is therefore necessary to study the effect of this sweetener on the body, and to investigate the ability of commonly eaten vegetables to ameliorate such effects. (Magnuson et al., 2007; Oboh et al., 2006; Kayode et al., 2010).

        1.3   AIM OF THE STUDY

      The aim of this study was to investigate the potentials of Amaranthus hybridus Linn. and Telfairia occidentalis Hook F. in combating aspartame– induced oxidative stress in rats.

        1.4   OBJECTIVES OF THE STUDY

1.         To determine the effect of leaf methanol extracts of Telfairia occidentalis and Amaranthus hybridus on lipid peroxidation via malondialdehyde formation in aspartame – treated rats.

2.         To determine the effect of leaf methanol extracts of Telfairia occidentalis and Amaranthus hybridus on the activities of some antioxidant enzymes namely catalase and superoxide dismutase

3.         To determine the effect of leaf methanol extracts of Telfairia occidentalis and Amaranthus hybridus on the serum lipid profile of aspartame – treated rats.

4.         To determine the effect of leaf methanol extracts of Telfairia occidentalis and Amaranthus hybridus on the liver enzyme activities of aspartame – treated rats.

5.         To determine the effect of leaf methanol extracts of Telfairia occidentalis and Amaranthus hybridus on the serum total protein, albumin and globulins concentrations in aspartame – treated rats.

6.         To determine the effect of leaf methanol extracts of Telfairia occidentalis and Amaranthus hybridus on some kidney function parameters namely serum urea and creatinine concentrations.

1.5       SCOPE

        The scope of this work covers biochemical assay of the lipid peroxidation marker, malondialdehyde, the antioxidant enzymes namely; catalase and superoxide dismutase, lipid profile, liver function and kidney function.

      1.6 SIGNIFICANCE OF THE STUDY

This study is significant because it will give insight into the health effect of excessive consumption of soft and energy drinks, candies or cookies which are the products in which aspartame is added as a sweetener to enhance taste. It will also give an insight to the health benefits /or otherwise of consumption of leafy vegetables particularly Telfairia occidentalis and Amaranthus hybridus used in this study. Furthermore, it will also contribute to the store of scientific information on medicinal plants which can be drawn upon by pharmaceutical industries for the production of new drugs.

         1.7    JUSTIFICATION OF THE STUDY

This study is justified by the fact that there is increasing need to create awareness on the subject of oxidative stress as the underlying cause of the increasing incidence of chronic debilitating diseases such as hypertension and stroke, diabetes mellitus, cancers, Alzheimer’s disease, Parkinson’s disease to mention but a few, which are major causes of mortality and morbidity in today’s world. There is need to educate people on ways they can prevent oxidative stress and the accompanying health hazards.

 

Click “DOWNLOAD NOW” below to get the complete Projects

FOR QUICK HELP CHAT WITH US NOW!

+(234) 0814 780 1594

Buyers has the right to create dispute within seven (7) days of purchase for 100% refund request when you experience issue with the file received. 

Dispute can only be created when you receive a corrupt file, a wrong file or irregularities in the table of contents and content of the file you received. 

ProjectShelve.com shall either provide the appropriate file within 48hrs or send refund excluding your bank transaction charges. Term and Conditions are applied.

Buyers are expected to confirm that the material you are paying for is available on our website ProjectShelve.com and you have selected the right material, you have also gone through the preliminary pages and it interests you before payment. DO NOT MAKE BANK PAYMENT IF YOUR TOPIC IS NOT ON THE WEBSITE.

In case of payment for a material not available on ProjectShelve.com, the management of ProjectShelve.com has the right to keep your money until you send a topic that is available on our website within 48 hours.

You cannot change topic after receiving material of the topic you ordered and paid for.

Ratings & Reviews

0.0

No Review Found.


To Review


To Comment